FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Losartan potassium 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 each gastro-resistant oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely venlafaxine 37.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Fenbufen 450 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Thioridazine hydrochloride 200 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Morphine sulfate 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Tetracycline 500 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Agalsidase beta 5 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Agalsidase beta 5 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Cefradine 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefradine 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefradine 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Amphotericin B 50 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amphotericin B 50 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Dantrolene sodium 20 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Dantrolene sodium 20 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 20 microgram powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Alprostadil 20 microgram powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely ceftazidime (as ceftazidime pentahydrate) 3 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ceftazidime (as ceftazidime pentahydrate) 3 gram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 40 microgram powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 40 microgram powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely doripenem (as doripenem monohydrate) 500 milligram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely doripenem (as doripenem monohydrate) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 5 microgram powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 5 microgram powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Alteplase 10 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Alteplase 10 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aztreonam 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aztreonam 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Aztreonam 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Aztreonam 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aztreonam 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Aztreonam 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aztreonam 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amobarbital sodium 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amobarbital sodium 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Basiliximab 10 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Basiliximab 10 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Basiliximab 20 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Basiliximab 20 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Diamorphine hydrochloride 10 mg powder for solution for injection ampule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Diamorphine hydrochloride 10 mg powder for solution for injection ampule Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 68 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start